Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LENALIDOMIDA MYLAN 15 mg CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LENALIDOMIDA MYLAN 15 mg CAPSULAS DURAS EFG

Approved

STANDARD

LENALIDOMIDA MYLAN 15 mg CAPSULAS DURAS EFG

Mylan Ireland Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 25, 2021
Approval ID: 4e28824b78d5a942
Company: Mylan Ireland Limited
Type: Standard

Approval Details

Approval Id: 4e28824b78d5a942
Drug Cima Aemps Name: LENALIDOMIDA MYLAN 15 mg CAPSULAS DURAS EFG
Register Number: 1201490012
Holder Company Name: Mylan Ireland Limited
Marketing Company Name: Viatris Pharmaceuticals S.L.U.
Holder Company Detail Path: /organization/mylan-ireland-limited
Authorization Date: 2021-06-25
Dosage Form: CÁPSULA DURA
Dose: 15 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Mylan Ireland Limited
Company Detail Path: /organization/mylan-ireland-limited

Company Information

Pharmaceutical Company Name: MYLAN IRELAND LIMITED
Country Name: Ireland
City Name: dublin,country_ie
Address: Legal Department
Website: http://www.mylan.ie

Active Ingredients

LENALIDOMIDA

15 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 25, 2021

Approval ID

4e28824b78d5a942

Type

Standard

Back to CIMA-AEMPS Approvals